siRNA delivery not Toll-free

被引：0

作者：

Michael P Gantier

Bryan R G Williams

机构：

[1] Michael P. Gantier and Bryan R.G. Williams are at the Centre for Cancer Research,

[2] Monash Institute of Medical Research,undefined

[3] Monash University,undefined

[4] Melbourne,undefined

[5] Victoria,undefined

[6] Australia.,undefined

来源：

Nature Biotechnology | 2009年 / 27卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Activating the tumor-associated immune system with an siRNA conjugated to a Toll-like receptor 9 ligand is a promising anticancer strategy.

引用

页码：911 / 912

页数：1

共 12 条

[1]

Aouadi M(2009)undefined Nature 458 1180-1184

[2]

MacDiarmid JA(2009)undefined Nat. Biotechnol. 27 643-651

[3]

Peer D(2008)undefined Science 319 627-630

[4]

Poeck H(2008)undefined Nat. Med. 14 1256-1263

[5]

Sato Y(2008)undefined Nat. Biotechnol. 26 431-442

[6]

Kortylewski M(2009)undefined Nat. Biotechnol. 27 925-932

[7]

Marques JT(2005)undefined Nat. Biotechnol. 23 1399-1405

[8]

Williams BR(2008)undefined Nature 452 591-597

[9]

Kleinman ME(2005)undefined Nat. Med. 11 1314-1321

[10]

Kortylewski M(2006)undefined Nat. Biotechnol. 24 1005-1015